Lab
Efficiency

Implementing the American Society of Echocardiography Ultrasound Enhancing Agent Guidelines Into Your Facility's Policy Helps to Ensure the Appropriate Use of DEFINITY® for Improved Patient Care1

Contrast Echo: See the Difference, Experience the Impact

Jonathan R. Lindner, MD, FACC, FASE, Lissa Sugeng, MD, MPH, FACC, FASE, Rajesh Janardhanan, MD, MCRP, FACC, FASE present the Lantheus 2015 ASE Science & Technology Theater Program.

DEFINITY® Delivers Clinical and Economic Value


Reduced resource utilization and per‑patient expenses2

DEFINITY® produced a 36% reduction for patient medication, procedures, or both.
Produced significant change in medications, procedures, or both in 36% of patients2

DEFINITY® helped 33% of patients avoid additional diagnostic procedures.
Helped 33% of patients avoid additional diagnostic procedures2

DEFINITY® helped reduce intensive care unit stays by 10%.
Reduced intensive care
unit stays by 10%2


Associated with changes in use of vasoactive medications3

DEFINITY® Improves Lab Efficiency and Workflow

Reduce
struggle time4

Decrease
procedure time5

May limit
sonographer injury5

DEFINITY® may increase patient throughput4,5
Peer-to-peer programs

Lantheus Medical Imaging offers multiple peer-to-peer programs to increase echo quality, enhance lab efficiency, reduce cost, and improve patient care.

Ask your DEFINITY® representative about peer‑to‑peer programs

IMPROVE quality program

DEFINITY® is committed to delivering customer value through the IMPROVE quality program.

  • Understand your suboptimal echo rate
  • Demonstrate the impact of DEFINITY® through improved image quality and a reduction in overall costs

DEFINITY® IMPROVE quality program logo.

CONTACT YOUR DEFINITY® REPRESENTATIVE

Sign up for DEFINITY® updates and announcements
SIGN UP HERE
Order DEFINITY® products
ORDER HERE
Explore the potential of DEFINITY® through our webinars
LEARN MORE
Order DEFINITY®
Products

References:

  1. Porter TR, Mulvagh SL, Abdelmoneim SS, et al. Clinical applications of ultrasonic enhancing agents in echocardiography: 2018 American Society of Echocardiography guidelines update. J Am Soc Echocardiogr. 2018:31(3):241-274.

  2. Main ML, Fu JW, Gundrum J, LaPointe NA, Gillam LD, Mulvagh SL. Impact of contrast echocardiography on outcomes in critically ill patients. Am J Cardiol. 2021;150:117-122.

  3. Kurt M, Shaikh KA, Peterson L, et al. Impact of contrast echocardiography on evaluation of ventricular function and clinical management in a large prospective cohort. J Am Coll Cardiol. 2009;53(9):802-810.

  4. Castello R, Bella JN, Rovner A, Swan J, Smith J, Shaw L. Efficacy and time-efficiency of a “sonographer-driven” contrast echocardiography protocol in a high-volume echocardiography laboratory. Am Heart J. 2003;145(3):535-541.

  5. Lester SJ, Askew JW, Hurst RT, et al. Contrast echocardiography: experience in a clinical echocardiography laboratory. J Am Soc Echocardiogr. 2006;19(7):919-923.